pharmaphorum

JANUARY 5, 2023

The deal centres on reSET and reSET-O, Pear’s cognitive behavioural therapy (CBT) based programmes, for people living with substance and opioid use disorders, respectively, which have been approved by the FDA as an adjunct to outpatient treatment. Pear secured approval for reSET-O in the following year.

Behavioural Health 52

Behavioural Health FDA Approval Licensing Licensing 52

pharmaphorum

SEPTEMBER 24, 2020

The FDA has awarded a breakthrough device designation to the app, which means it should have a swift review with a higher level of input from the US regulator. In the US, it is estimated that one in five children are living with a diagnosable behavioural health disorder, however, only 21% of children who are diagnosed receive treatment.

Behavioural Health 134

Behavioural Health Doctors Doctor Development 134

pharmaphorum

JANUARY 26, 2021

There is an opportunity to address this at scale with digital tools and techniques, and expand support into just about any therapeutic area through the holistic integration of mental and behavioural health solutions that improve patient care.

Clinical Trials 141

Clinical Trials Clinical Trials Sales Life Science 141